Laden…
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Midazolam is a short-acting benzodiazepine primarily used for sedation, anxiolysis, and as an anticonvulsant. It acts by enhancing GABAergic inhibition in the central nervous system. Due to its pharmacological profile, it is frequently used in anesthesia and emergency medicine. The substance has a high potential for dependence and can lead to respiratory depression if misused.
Class
Not clearly classified yet
Pharmacological context
Mechanism
Mechanism of action of Midazolam (Unknown): Data is being researched.
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Mechanism of Action
Designations
IUPAC: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology is partially translated. Some details are still being expanded.
Mechanism of action of Midazolam (Unknown): Data is being researched.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 5–15 mg
Total duration 2–6 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 2–5 mg |
| Reported | 5–15 mg |
| Strong | 15–30 mg |
IV
| Tier | Dosage |
|---|---|
| Light | 0.5–1 mg |
| Reported | 1–5 mg |
| Strong | 5–10 mg |
Onset
1–5 minutes (IV), 30 minutes (oral)
Peak
1–2 hours
Total duration
2–6 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Risiko von Abhängigkeit, Atemdepression und Sedierung.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.